查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
體外診斷市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品和服務、技術、應用、最終用戶和地理位置
市場調查報告書
商品編碼
1362385

體外診斷市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品和服務、技術、應用、最終用戶和地理位置

In-Vitro Diagnostic Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product & Service, Technology, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 210 Pages | 訂單完成後即時交付

價格

體外診斷市場預計將從2022年的723.938億美元成長到2030年的1121.0351億美元；預計2022年至2030年年複合成長率為5.6%。慢性病盛行率不斷上升、技術進步和老年人口不斷成長是推動體外診斷市場成長的值得注意因素。

體外診斷(IVD)是對從人體採集的血液或組織等樣本進行的測試。體外診斷專門用於檢測疾病或其他狀況，可用於監測人的整體健康狀況，以幫助治癒、治療或預防疾病。此外，體外診斷也可用於精準醫學，以確定可能受益於特定治療或療法的患者。因此，這些體外診斷可以包括次世代定序測試，掃描人類的 DNA 以檢測基因組變異。

慢性病和傳染病的盛行率不斷增加

世界傳染病的流行呈指數級成長。這些疾病主要是由病毒、細菌、寄生蟲等病原微生物引起的。衛生條件差、缺乏公共衛生、空氣污染嚴重以及無法獲得安全飲用水等因素在加劇傳染病流行方面發揮重要作用。據加拿大公共衛生局指出，2020年該國總共報告了 6,736 例丙型肝炎病例(急性、慢性和未明確的合計)。

慢性病主要包括癌症、慢性呼吸道疾病、糖尿病和心臟病。由於生物風險因素，例如酒精和菸草消費增加、不健康飲食、缺乏體力活動和肥胖流行等，這些疾病的發生率在全球範圍內急劇上升。慢性病是全球死亡的主要原因。根據美國疾病管制與預防中心(CDC)的資料，十分之六的美國人患有至少一種慢性疾病，例如中風、癌症、心臟病或糖尿病。這些慢性疾病是美國死亡和殘疾以及醫療費用迅速成長的主要原因；2021年，該國的醫療保健費用約為 4.1 兆美元。疾病預防控制中心的資料還表明，心臟病是男性、女性以及大多數種族和族裔群體的主要死亡原因。

根據疾病預防控制中心的資料，冠狀動脈疾病(CAD)是成年人死亡的最常見原因。2021年，約 375,476 人死於 CAD。世界衛生組織《2022年國家糖尿病統計報告》中發布的估計表明，全球約有 4.22 億人患有糖尿病，其中大多數生活在低收入和中等收入國家。此外，每年有150萬人死亡與糖尿病有直接關係。超重、遺傳條件、老化、久坐的生活方式等日益增加糖尿病的盛行率。根據英國癌症研究中心發布的報告估計，2020年全球新增癌症病例約為1,810 萬例，預計到2040年這一數字將增加至2,800 萬例。因此，傳染病和慢性病的盛行率不斷上升，例如心血管疾病、癌症、糖尿病和呼吸系統疾病推動了體外診斷市場的成長。

市場趨勢

對個人化醫療和基因組學的需求不斷成長

北美處於個人化醫療和基因組學研究的前沿。基因組學和分子診斷擴大融入日常患者護理中。參與開發先進遺傳學的公司在體外診斷市場上擁有大量機會。北美，特別是美國和加拿大，一直是基因組研究中心的中心，這些中心對疾病遺傳基礎的理解和知識、生物標記的識別和標靶治療的開發做出了顯著貢獻。這兩個國家都啟動了精準醫學計劃，將基因組學涵蓋臨床實踐。北美一直是癌症基因組學領域的領導者，並進行了大量研究和臨床試驗，重點是了解與不同類型癌症相關的遺傳因素。這些試驗目的是評估標靶療法、免疫療法和其他基於患者腫瘤遺傳特徵的創新療法的療效。美國癌症協會估計，到2023年，美國將新增 190 萬癌症病例(約每天 5,370 例)，並有 609,820 人死於癌症。由於發病率如此之高，迫切需要有效的治療來提高這些患者。

個人化醫療包括對患者進行體外診斷測試，根據其獨特特徵將其分為亞組。個人化醫療領域，加上基因組定序、分子分析和其他診斷技術的進步，有可能透過提供有針對性、精確和個人化的治療方法來徹底改變醫療保健。遺傳學在全球範圍內變得越來越容易獲得。2022年11月，羅氏、英國癌症研究中心和曼徹斯特大學宣布啟動多藥精準醫學DETERMINE試驗。該試驗目的是評估可用的藥物(包括那些被許可用於更常見癌症類型的藥物)是否可以使罕見癌症類型的患者受益。該試驗招募了患有罕見癌症類型的成人和兒童患者。 23and Me 和 AncestryDNA 等公司提供直接面對消費者的基因檢測試劑盒，使個人能夠深入了解自己的血統、遺傳特徵和潛在的健康風險。醫療保健提供者還提供基因檢測來指導治療決策。因此，對個人化醫療和基因組學的需求將推動預測期內體外診斷市場的成長。

「全球體外診斷市場」根據產品和服務、應用、技術、最終用戶和地理位置進行細分。根據產品和服務，市場分為試劑和試劑盒、儀器、軟體和服務。2022年，試劑和試劑盒細分市場佔據最大市場佔有率。試劑和試劑盒市場的預期成長歸因於自檢試劑盒和 POC 設備的巨大普及，以及簡化工作並提供準確結果的自動化儀器的可用性和採用率的增加。病毒和真菌感染病例的增加以及衛生條件不足促進了試劑的使用。因此，體外診斷市場的參與者提供優質的分子試劑和試劑盒，以更佳管理和照顧患者。

歐洲藥品管理局、緊急使用授權、疾病管制與預防中心、國際糖尿病聯盟、體外診斷研究是準備體外診斷市場研究報告時參考的一些相關來源。

目錄

第1章 簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第2章 執行摘要

  • 重要見解
  • 體外診斷市場(按地理位置)

第3章 研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第4章 體外診斷市場格局

  • 概述
  • PEST分析
    • PEST分析

第5章 體外診斷市場 - 主要產業動態

  • 主要市場促進因素
    • 慢性病和傳染病的盛行率不斷增加
    • COVID-19 大流行期間體外診斷需求激增
  • 市場約束
    • 監理框架和償付政策不足
  • 市場機會
    • IVD 與數位健康科技的整合
  • 未來的趨勢
    • 對個人化醫療和基因組學的需求不斷成長

第6章 體外診斷市場 - 全球市場分析

  • 體外診斷市場收入，2022 -2030

第7章 全球體外診斷市場 - 收入和2030年預測 - 依產品和服務

  • 概述
  • 2022年和2030年依產品和服務分類的體外診斷市場收入佔有率(%)
  • 試劑和試劑盒
  • 軟體和服務
  • 儀器

第8章 全球體外診斷市場 - 收入和2030年預測 - 依技術分類

  • 概述
  • 2022年和2030年依技術分類的體外診斷市場收入佔有率(%)
  • 免疫測定/免疫化學
  • 臨床化學
  • 分子診斷
  • 微生物學
  • 血糖自我監測
  • 凝血與止血
  • 血液學
  • 尿液分析
  • 其他

第9章 全球體外診斷市場 -2030年收入和預測 -依應用

  • 概述
  • 2022年及2030年依應用分類的體外診斷市佔率(%)
  • 傳染病
  • 糖尿病
  • 腫瘤學
  • 心臟病學
  • 自體免疫疾病
  • 腎臟病學
  • 其他

第10章 全球體外診斷市場 - 收入和2030年預測 - 依最終用戶

  • 概述
  • 2022年及2030年最終用戶體外診斷市場收入佔有率(%)
  • 醫院
  • 實驗室
  • 居家護理
  • 其他

第11章 體外診斷市場 -2030年收入與預測 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第12章 產業格局

  • 概述
  • 北美體外診斷市場的成長策略
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第13章 公司簡介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Danaher Corp
  • Siemens AG
  • Sysmex Corp
  • Thermo Fisher Scientific Inc
  • Becton Dickinson and Co
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • Qiagen NV

第14章 附錄

  • 關於我們
  • 專業術語
Product Code: TIPBT00002657

The in-vitro diagnostics market is expected to grow from US$ 72,393.80 million in 2022 to US$ 1,12,103.51 million by 2030; it is expected to grow at a CAGR of 5.6% from 2022 to 2030. The increasing prevalence of chronic diseases, technological advancements, and the growing geriatric population are the noteworthy factors driving the in-vitro diagnostics market growth.

In vitro diagnostics (IVD) are tests done on samples such as blood or tissues that have been taken from the human body. In-vitro diagnostics are specialized to detect diseases or other conditions that can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Additionally, in-vitro diagnostics may also be utilized for precision medicine to identify patients who are likely to benefit from specific treatments or therapies. Therefore, these in-vitro diagnostics can include next-generation sequencing tests that scan a person's DNA to detect genomic variations.

Increasing Prevalence of Chronic and Infectious Diseases

The world is witnessing an exponential increase in the prevalence of infectious diseases. These diseases are prominently caused due to pathogenic microorganisms, such as viruses, bacteria, and parasites. Factors such as poor sanitary conditions, lack of public hygiene, elevating levels of air pollution, and unavailability of safe drinking water play a significant role in the bolstering prevalence of infectious diseases. According to the Public Health Agency of Canada, the country reported a total of 6,736 cases of hepatitis C (acute, chronic, and unspecified combined) in 2020.

Chronic diseases prominently include cancer, chronic respiratory diseases, diabetes, and heart disease. The incidences of these conditions are skyrocketing globally due to biological risk factors, such as an increase in alcohol and tobacco consumption, adoption of unhealthy diets, lack of physical activity, and prevalence of obesity. Chronic conditions are the leading cause of mortality globally. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 Americans live with at least 1 chronic disease, such as stroke, cancer, heart disease, or diabetes. These chronic diseases are the leading causes of death and disabilities, and burgeoning healthcare costs in the US; the country's healthcare cost was ~US$ 4.1 trillion in 2021. The CDC data also suggests that heart disease is the leading cause of death among men, women, and people of most racial and ethnic groups.

According to CDC data, coronary artery disease (CAD) is the most common cause of mortality among adults. Approximately 375,476 people died due to CAD in 2021. Estimates published in the 2022 National Diabetes Statistics Report by the World Health Organization state that ~422 million people worldwide have diabetes, the majority living in low-and middle-income countries. Moreover, 1.5 million deaths are directly related to diabetes each year. overweight, genetic conditions, aging, sedentary lifestyle, etc., are boosting the prevalence of diabetes. According to estimations published in a Cancer Research UK report, ~18.1 million new cancer cases were reported in the world in 2020, and the number is expected to increase to 28 million by 2040. Hence, the rising prevalence of infectious and chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory conditions drives the growth of the in-vitro diagnostics market.

Market Trend

Increasing Demand for Personalized Medicine and Genomics

North America is at the forefront of personalized medicine and genomics research. There is increasing integration of genomics and molecular diagnostics into routine patient care. Companies are involved in developing advanced genetics hold substantial opportunities for the in-vitro diagnostics market. North America, particularly the US and Canada, has been a hub for genomic research centers that contribute notably to understanding and knowledge on the genetic basis of diseases, identification of biomarkers, and development of targeted therapies. Both these countries have launched precision medicine initiatives to integrate genomics into clinical practices. North America has been a leader in cancer genomics, hosting extensive research and clinical trials focused on understanding the genetic factors associated with different types of cancer. These trials aim to evaluate the efficacy of targeted therapies, immunotherapies, and other innovative treatments based on the genetic characteristics of patients' tumors. The American Cancer Society estimates that the US would record 1.9 million new cancer cases (~5,370 cases per day) and 609,820 deaths from cancer in 2023. With such a high incidence, there is a pressing need for effective treatment to improve the quality of life of these patients.

Personalized medicine involves running in-vitro diagnostics tests on patients to stratify them into subgroups based on their unique characteristics. The field of personalized medicine, along with advancements in genomics sequencing, molecular profiling, and other diagnostic technologies, has the potential to revolutionize healthcare by providing targeted, precise, and individualized treatment approaches. Genetics have become increasingly accessible globally. In November 2022, Roche, Cancer Research UK, and the University of Manchester announced the launch of a multidrug, precision medicine DETERMINE trial. The trial seeks to evaluated if available agents, including those that are licensed for more common cancer types, could benefit patients with rare cancer types. The trial recruited both adult and pediatric patients with rare cancer types. Companies such as 23and Me and AncestryDNA offer direct-to-consumer genetic testing kits, allowing individuals to gain insights into their ancestry, genetic traits, and potential health risks. Healthcare providers also offer genetic testing to guide treatment decisions. Thus, the demand for personalized medicine and genomics will propel the growth of the in-vitro diagnostics market during the forecast period.

The "Global In-Vitro Diagnostic Market" is segmented on the basis of product and service, application, technology, end user, and geography. Based on product and service, the market is segmented into reagents and kits, instruments, and software and services. In 2022, the reagents and kits segment held the largest share of the market. The projected growth of the market for reagents and kits is attributed to the tremendous popularity of self-test kits and POC devices, and a rise in availability and adoption automated instruments that simplify jobs and provide accurate results. The increasing cases of viral and fungal infections with inadequate hygienic conditions promote reagent use. Thus, players in the in-vitro diagnostics market are offering superior quality molecular reagents and kits for better patient management and care.

European Medicines Agency, Emergency Use Authorization, Centers for Disease Control and Prevention, International Diabetes Federation, In-Vitro Diagnostic Research are some of the relevant sources referred while preparing the in-vitro diagnostics market research report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the in-vitro diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global in-vitro diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 In-Vitro Diagnostics Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. In-Vitro Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 PEST Analysis

5. In-Vitro Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
    • 5.1.2 Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic
  • 5.2 Market Restraint
    • 5.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
  • 5.3 Market Opportunities
    • 5.3.1 Integration of IVD with Digital Health Technologies
  • 5.4 Future Trends
    • 5.4.1 Increasing Demand for Personalized Medicine and Genomics

6. In-Vitro Diagnostics Market - Global Market Analysis

  • 6.1 In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 7.1 Overview
  • 7.2 In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 7.3 Reagents and Kits
    • 7.3.1 Overview
    • 7.3.2 Reagents and Kits: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Software and Services
    • 7.4.1 Overview
    • 7.4.2 Software and Services: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Instruments
    • 7.5.1 Overview
    • 7.5.2 Instruments: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Immunoassay/ Immunochemistry
    • 8.3.1 Overview
    • 8.3.2 Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinical Chemistry
    • 8.4.1 Overview
    • 8.4.2 Clinical Chemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Molecular Diagnostics
    • 8.5.1 Overview
    • 8.5.2 Molecular Diagnostics: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Microbiology
    • 8.6.1 Overview
    • 8.6.2 Microbiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Blood Glucose Self-Monitoring
    • 8.7.1 Overview
    • 8.7.2 Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Coagulation and Hemostasis
    • 8.8.1 Overview
    • 8.8.2 Coagulation and Hemostasis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Hematology
    • 8.9.1 Overview
    • 8.9.2 Hematology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Urinalysis
    • 8.10.1 Overview
    • 8.10.2 Urinalysis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.11 Others
    • 8.11.1 Overview
    • 8.11.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • 9.3 Infectious Disease
    • 9.3.1 Overview
    • 9.3.2 Infectious Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diabetes
    • 9.4.1 Overview
    • 9.4.2 Diabetes: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Oncology
    • 9.5.1 Overview
    • 9.5.2 Oncology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Cardiology
    • 9.6.1 Overview
    • 9.6.2 Cardiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Autoimmune Diseases
    • 9.7.1 Overview
    • 9.7.2 Autoimmune Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.8 Nephrology
    • 9.8.1 Overview
    • 9.8.2 Nephrology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.9 Others
    • 9.9.1 Overview
    • 9.9.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Laboratories
    • 10.4.1 Overview
    • 10.4.2 Laboratories: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Homecare
    • 10.5.1 Overview
    • 10.5.2 Homecare: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Geographic Analysis

  • 11.1 North America: In-Vitro Diagnostics Market
    • 11.1.1 Overview
    • 11.1.2 North America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.1.3 North America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    • 11.1.4 North America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    • 11.1.5 North America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    • 11.1.6 North America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
    • 11.1.7 North America: In-Vitro Diagnostics Market, by Country
      • 11.1.7.1 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.3 US: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.1.7.1.4 US: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.7.1.5 US: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.1.6 US: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.1.7.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.3 Canada: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.1.7.2.4 Canada: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.7.2.5 Canada: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.2.6 Canada: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.1.7.3 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.3 Mexico: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.1.7.3.4 Mexico: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.1.7.3.5 Mexico: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.3.6 Mexico: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  • 11.2 Europe: In-Vitro Diagnostics Market
    • 11.2.1 Overview
    • 11.2.2 Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.2.3 Europe: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    • 11.2.4 Europe: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    • 11.2.5 Europe: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    • 11.2.6 Europe: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
    • 11.2.7 Europe: In-Vitro Diagnostics Market, by Country
      • 11.2.7.1 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.1.3 Germany: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.1.4 Germany: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.1.5 Germany: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.1.6 Germany: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.2 France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.2.3 France: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.2.4 France: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.2.5 France: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.2.6 France: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.3 UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.3.3 UK: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.3.4 UK: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.3.5 UK: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.3.6 UK: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.4 Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.4.3 Italy: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.4.4 Italy: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.4.5 Italy: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.4.6 Italy: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.5 Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.5.3 Spain: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.5.4 Spain: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.5.5 Spain: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.5.6 Spain: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.6 Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.6.3 Rest of Europe: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.2.7.6.4 Rest of Europe: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.2.7.6.5 Rest of Europe: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.6.6 Rest of Europe: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  • 11.3 Asia Pacific: In-Vitro Diagnostics Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.3.3 Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    • 11.3.6 Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
    • 11.3.7 Asia Pacific: In-Vitro Diagnostics Market, by Country
      • 11.3.7.1 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.3 China: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.1.4 China: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.1.5 China: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.1.6 China: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.2 Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.3 Japan: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.2.4 Japan: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.2.5 Japan: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.2.6 Japan: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.3 India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.3 India: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.3.4 India: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.3.5 India: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.3.6 India: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.4 Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.3 Australia: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.4.4 Australia: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.4.5 Australia: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.4.6 Australia: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.5 South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.3 South Korea: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.5.4 South Korea: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.5.5 South Korea: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.5.6 South Korea: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.6 Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.3 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.3.7.6.4 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.3.7.6.5 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.6.6 Rest of Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa: In-Vitro Diagnostics Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.4.3 Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    • 11.4.6 Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
    • 11.4.7 Middle East & Africa: In-Vitro Diagnostics Market, by Country
      • 11.4.7.1 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.3 South Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.4.7.1.4 South Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.7.1.5 South Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.1.6 South Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.2 Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.3 Saudi Arabia: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.4.7.2.4 Saudi Arabia: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.7.2.5 Saudi Arabia: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.2.6 Saudi Arabia: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.3 UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.3 UAE: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.4.7.3.4 UAE: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.7.3.5 UAE: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.3.6 UAE: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.3 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.4.7.4.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.7.4.5 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.4.6 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  • 11.5 South & Central America: In-Vitro Diagnostics Market
    • 11.5.1 Overview
    • 11.5.2 South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.5.3 South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    • 11.5.6 South & Central America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
    • 11.5.7 South & Central America: In-Vitro Diagnostics Market, by Country
      • 11.5.7.1 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.1.3 Brazil: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.5.7.1.4 Brazil: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.7.1.5 Brazil: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.1.6 Brazil: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.5.7.2 Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.2.3 Argentina: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.5.7.2.4 Argentina: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.7.2.5 Argentina: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.2.6 Argentina: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
      • 11.5.7.3 Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.3.3 Rest of South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
        • 11.5.7.3.4 Rest of South & Central America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
        • 11.5.7.3.5 Rest of South & Central America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.3.6 Rest of South & Central America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in North America In-Vitro Diagnostics Market
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 F. Hoffmann-La Roche Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Danaher Corp
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Siemens AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Sysmex Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Thermo Fisher Scientific Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Becton Dickinson and Co
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 bioMerieux SA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Bio-Rad Laboratories Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Qiagen NV
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. In-Vitro Diagnostics Market Segmentation
  • Table 2. North America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Europe In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Germany In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Germany In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Germany In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Germany In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. France In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. France In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. France In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. France In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. UK In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. UK In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. UK In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Italy In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Italy In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Italy In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Italy In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Spain In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Spain In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Spain In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Spain In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Rest of Europe In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Rest of Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Rest of Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Rest of Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Asia Pacific In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Death Rate Of Cancer in 2020 Globally
  • Table 51. China In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. China In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. China In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. China In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Japan In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Japan In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Japan In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Japan In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. India In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. India In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. India In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. India In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Australia In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Australia In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Australia In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Australia In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. South Korea In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. South Korea In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. South Korea In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. South Korea In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Rest of Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Rest of Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Rest of Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Rest of Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Middle East & Africa In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Middle East & Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Middle East & Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Middle East & Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. South Africa In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. South Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. South Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Saudi Arabia In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Saudi Arabia In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Saudi Arabia In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Saudi Arabia In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. UAE In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. UAE In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. UAE In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. UAE In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Rest of Middle East & Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. Brazil In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Brazil In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Brazil In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Brazil In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Argentina In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. Argentina In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Argentina In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Argentina In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Rest of South & Central America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Organic Developments Done by Companies
  • Table 111. Inorganic Developments Done by Companies
  • Table 112. Glossary of Terms, In-Vitro Diagnostics Market

List Of Figures

  • Figure 1. In-Vitro Diagnostics Market Segmentation, By Geography
  • Figure 2. PEST Analysis
  • Figure 3. In-Vitro Diagnostics Market: Key Industry Dynamics
  • Figure 4. In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 5. In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. Global In-Vitro Diagnostics Market, By Geography Forecast Analysis, 2022 & 2030
  • Figure 7. In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 8. Reagents and Kits: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Software and Services: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Instruments: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 12. Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Clinical Chemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Molecular Diagnostics: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Microbiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Coagulation and Hemostasis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Hematology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Urinalysis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 22. Infectious Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Diabetes: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Oncology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Cardiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Autoimmune Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Nephrology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 30. Hospitals: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Laboratories: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Homecare: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. North America: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 35. North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. North America: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 37. US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Europe: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 41. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. Europe: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 43. Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 47. Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 48. Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 49. Asia Pacific: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 50. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. Asia Pacific: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 52. China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 55. Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 56. South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 57. Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 58. Middle East & Africa: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 59. Middle East & Africa In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 60. Middle East & Africa: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 61. South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 62. Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 63. UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 64. Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 65. South & Central America: In-Vitro Diagnostics Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 66. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 67. South & Central America: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 68. Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 69. Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 70. Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 71. Growth Strategies in North America In-Vitro Diagnostics Market